During the acute stage constitutional symptoms such as weight loss, night sweats, malaise and fever are extremely common, affecting half of the patients.
The patient did not recall a previous acute Q fever episode, and she had not experienced fever, night sweats, malaise, or weight loss.
4, 5 The symptoms of the disease are nonspecific but the majority of patients, in the acute form, complain of fever (over 38.5°C), sweats, malaise, anorexia, headache, arthralgia, and backache.
Most patients with mycobacterial-disease complicating pneumycobacterial-disease complicatingigns and sympneumoconiosisfever, night sweats, malaise, and worsening respresenty findings (Snider 1978), although the disease could be paucisymptomatic in many patients (Solomon 2001).
Human brucellosis is a systemic infection that may manifest with a myriad of non-specific symptoms (e.g., fever, sweats, malaise, anorexia, headache, back pain) as well as substantial residual disability.
The following inclusion criteria were used: persistent cough for ≥ 2 weeks and at least two other TB associated findings (haemoptysis, chest pain, fever, night sweats, malaise, recent unexplained weight loss, loss of appetite, contact with TB case), the ability to comply with study procedures such as sample collection and no TB treatment during the past 2 months.
In August 2000, a 38-year-old Thai man came to an outpatient department of King Chulalongkorn Memorial Hospital, Bangkok, with daily fever, headache, intermittent chill, sweating, and malaise for 4 days.
Human brucellosis may lead to a variety of clinical presentations, such as fever, sweating, chills, headache, malaise, myalgia and even arthralgia of the large joints [ 3].
Other events occurring significantly more frequently with rivastigmine 6 to 12 mg/day than with placebo are dizziness, headache, fatigue, malaise, sweating, asthenia, somnolence, dyspepsia, and sinusitis (p < 0.05).
